WASHINGTON — Some days, President Trump vows to eliminate them.

But then, there are days when his top health lieutenants promise to empower them. There are even days when they do both.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Excellent article, Ike. Perhaps, a grassroots-level effort needs to be mounted by a consortium of patient-centric organization. As Malhotra says in his comment, it’s no rocket science to figure out a win-win cost structure; if only we could keep the lobbyists out.

  • It is hard to make policy when Industry Insiders control the dialogue. We are so far past any kind of sensible legislation. The “Fix” is in, the are going to do the same thing the Industries did to the A.C.A. Anything this guy comes up with, will be in response to whatever false narrative Pharma and their complicit journalists and media outlets is peddling this week. The obscene amounts of profits have undermined our elected officials, policy makers and even the facts. It is time for Universal Healthcare, the only solution here. the Fact that they are discussing the broken corrupt system is further proof. We are already paying for these schemes, and corrupt officials, are too conflicted by industry money and misinformation.

  • I love it that a health care lobbyist said “we don’t have a clue.” This is a positive change from them driving policy on behalf of special interests that don’t include the patient.

  • “If you figure out what Trump’s up to, let me know,” one health care lobbyist said. “We don’t have a clue.”

    The most significant question is, “why is the executive branch of the federal government, still creating obstacles for prescribing physicians, and intent on overseeing the relationship between the physicians and their patients?”

    The person who has the least of care and compassion, still is insinuating himself in our lives, with earnestly attempts, to create the new “world order,” to which, he and his bff, are truly the most benefitial recipients, than all the pharmas’ combined.

    I will never stop speaking to the reprehensible individuals who have no right to be in the treatment rooms of any citizens, in a once democratic nation.

    The appointment of the head of the regulation committees are as responsible for the current, seemingly criminal behaviors that are of no benefit for the citizens who have rights that, in my opinion, are not being honored. That branch of our federal government, is a significant problem with everything that is chaotic and rife with consequences for our citizens; the only individuals who are benefiting from their intrusion into our private health care practitioners and us, is every single one of them!

  • With so much of brain power we have it is an easy exercise to figure out the cost structure of drugs. One can easily see that PBMs are gouging the system and they will not roll over and play dead and let the go of the golden goose.
    The following analysis tells us the story.

    Flow of Money Through the Pharmaceutical Distribution System (https://healthpolicy.usc.edu/research/flow-of-money-through-the-pharmaceutical-distribution-system/)

    PBMs are going to kill every path that will lower their profits. Be aware lobbyists you will need to sharpen your pencils.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy